Amphion Innovations (AMP)
market vs.
industry GROWTH & VALUE
| Trailing 12m | ||||
| PE Ratio (ttm) | 4.46 |
|
|
|
| PEG Ratio (ttm) |
|
|
||
| EPS Growth (ttm) | % |
|
|
|
| Dividend Yield (ttm) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 0.18 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | TTM | 2012E | 2013E | CAGR / Avg | |
| Revenue | $m | ||||||||||
| Operating Profit | $m | ||||||||||
| Net Profit | $m | ||||||||||
| EPS Reported | $ | ||||||||||
| EPS Normalised | $ | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | $ | ||||||||||
| Capex ps | $ | ||||||||||
| Free Cashflow ps | $ | ||||||||||
| Dividends | |||||||||||
| Dividend ps | $ | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | $m | ||||||||||
| Working Capital | $m | ||||||||||
| Net Fixed Assets | $m | ||||||||||
| Net Debt | $m | ||||||||||
| Book Value | $m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | $ | -10.4% | |||||||||
FINANCIAL BRIEF: For the six months ended 30 June 2012, Amphion Innovations Plc revenues decreased 59% to $1.1M. Net income increased from $198K to $3M. Revenues reflect Intellectual Property segment decrease of 75% to $500K, United States segment decrease of 63% to $920K. Net income reflects Investing segment loss decrease of 30% to $508K. Basic Earnings per Share excluding Extraordinary Items totaled to more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 30th Jun '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: |
Amphion Innovations PLC is a United Kingdom-based private equity firm that build shareholder value in growth companies in the medical and technology sectors. The Firm uses a hands-on company building approach. It has a shareholding in seven Partner Companies developing technologies targeting commercial marketplaces, each in excess of $1 billion. Amphion also has a specialized entity, DataTern, Inc., established to exploit IP opportunities within the Company's Partner Companies.
Directors: Robert Bertoldi (Pres.) , Richard Morgan (CEO) , John Caruso (Mgng.Dir.) , Jerel Whittingham (Exec. Dir.) , Andrew Baker (Secy.) ,
No. of Employees: 7 No. of Shareholders: n/a
| Last Annual | December 31st, 2011 |
| Last Interim | June 30th, 2012 |
| Shares in Issue | 135,600,250 |
| Free Float | 51.4m (37.9%) |
| Sector | Financials |
| Industry | Investment Banking & Investment Services |
| Index | FTSE Aim All Share, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | 330 Madison Avenue, NEW YORK, 10017, United States |
| Web | http://www.amphionplc.com/ |
| Phone | +1 212 2106282 |
| Contact | Ankrew J. Baker (Secy.) |
| Registrar | Neville Registrars |
| Auditors | KPMG Audit PLC |
| 18th Apr | Director/PDMR Shareholding |
| 17th Apr | Trading Statement |
| 28th Mar | Change of Adviser |
| 19th Dec '12 | Holding(s) in Company |
| 13th Dec '12 | Fundraising |
| 5th Dec '12 | Amphion announces new partnership with Motif |
